AI Assisted Learning is Fastest Growing Segment Fueling the Growth of Cell Therapy Manufacturing Market
The global Cell Therapy Manufacturing Market is estimated to be valued at US$ 12.99 Mn in 2023 and is expected to exhibit a CAGR of 15% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Cell therapy manufacturing involves development and expansion of cells that
can repair or replace damaged tissues and cells. The growing prevalence of
chronic diseases such as cancer has increased the demand for cell therapies.
Market key trends:
AI assisted learning has emerged as a major trend in cell therapy
manufacturing. AI and machine learning algorithms are used for cell selection,
characterization, expansion and monitoring. They help optimize manufacturing
processes, improve quality control and productivity. AI also helps design
personalized medicine approaches in cell therapy. It analyses huge amounts of
patient data to determine best treatment options.
Segment Analysis
The global
cell therapy manufacturing market size is segmented on the basis of
type, end user, and geography. By type, the market is segmented into stem
cells, immune cells, and other types of cells. The stem cells segment dominates
the market as stem cells have wide applications in research, development of new
therapies, and treatment of various diseases. Stem cells can be differentiated
into different cell types of the body and they are constantly renewing
themselves through cell division. Due to their self-renewal capacity and
ability to differentiate, stem cells have great potential for the development
of cell-based therapies and regenerative medicines to treat diseases.
Key Takeaways
The global cell therapy manufacturing market size is expected to reach US$
12.99 Mn in 2023 and is anticipated to grow at a CAGR of 15% during the
forecast period of 2023 to 2030. The high growth is attributed to rising
incidences of chronic diseases and increasing investments in cell-based
research.
Regional analysis - North America dominates the global cell therapy
manufacturing market. The presence of advanced healthcare infrastructure,
prominent market players, and rising adoption of cell therapy are key factors
responsible for its dominance. Asia Pacific is anticipated to witness the
fastest growth over the coming years owing to growing public awareness about
cell therapy, increasing government support, and rising healthcare expenditure
in the region.
Key players - Key players operating in the cell therapy manufacturing market
are WuXi AppTec, Inc., Lineage Cell Therapeutics, Inc., HEALIOS K.K., Lonza,
Merck KGaA., Takara Bio Inc., Sumitomo Dainippon Pharma Co., LTD, Fujifilm Holdings
Corporation, Thermo Fisher Scientific, Inc., and Astellas Pharma Inc. Of these,
WuXi AppTec, Inc. dominates the market owing to its global presence and strong
manufacturing capabilities.
Get
more insights on this topic: https://www.newsstatix.com/cell-therapy-manufacturing-market-share-and-opportunity-analysis/
Explore
more information, Please visit: https://www.newsintv.com/news/offshore-the-decommissioning-a-best-growing-sector/
Comments
Post a Comment